Please login to the form below

Not currently logged in
Email:
Password:

The Grey Healthcare Group Award for Excellence in Health Improvement and Education

Sponsored by

Finalist

Think Test for HIV

Bristol-Myers Squibb in association with Mash Health


Summary of work

Late diagnosis of HIV remains an issue in the UK, affecting morbidity and mortality. While guidelines set out criteria for testing outside the genitourinary medicine (GUM) setting, testing in other specialties remains low. 

We worked with Bristol-Myers Squibb to develop a programme designed to increase HIV testing in non-GUM Secondary Care settings. In the 10 months since launch, the ‘Think Test for HIV’ initiative has been adopted in more than 38 hospitals. In one hospital, this has already resulted in a 60 per cent increase in HIV testing and a 13 per cent increase in early diagnosis – directly impacting on patients’ lives.

 

 

Executive summary as submitted


Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....